medigraphic.com
SPANISH

Anales Médicos de la Asociación Médica del Centro Médico ABC

ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2022; 67 (1)

Radiotherapy induced breast morphea: an unusual complication

Hernández-Montes OR, Anaya-Jiménez RM, Heredia-Nieto OA, Magallanes-Maciel ME
Full text How to cite this article 10.35366/104370

DOI

DOI: 10.35366/104370
URL: https://dx.doi.org/10.35366/104370

Language: Spanish
References: 17
Page: 61-65
PDF size: 331.96 Kb.


Key words:

Morphea, localized scleroderma, radiotherapy.

ABSTRACT

Radiotherapy induced morphea is a rare complication of unknown etiology, which is diagnosed through exclusion and managed with unstandardized treatment. A 51-year-old woman with a past medical history of rheumatoid arthritis and breast cancer arrived at our clinic due to localized burning pain of the left breast with warm erythematous thickening of the skin, peau d'orange, non-pitting edema and nipple retraction three months after concluding her last radiotherapy session. She was treated with antibiotic, analgesic and anti-inflammatory drugs without improvement. We took a biopsy of the lesion and they reported fibrosis in the dermis and subcutaneous cellular tissue, atrophy of hair follicles and absence of adnexa, findings highly suggestive of morphea induced by radiotherapy. When recurrence was ruled out, we started topical treatment with steroids and systemic anti-inflammatory drugs, notably improving the condition.


REFERENCES

  1. Fehlauer F, Tribius S, Holler U, Rades D, Kuhlmey A, Bajrovic A et al. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys. 2003; 55 (3): 651-658.

  2. Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015; 90 (1): 62-73.

  3. Bleasel NR, Stapleton KM, Commens C, Ahern VA. Radiation-induced localized scleroderma in breast cancer patients. Australas J Dermatol. 1999; 40 (2): 99-102.

  4. Partl R, Regitnig P, Tauber G, Potscher M, Bjelic-Radisic V, Kapp KS. Radiation-induced morphea—a rare but severe late effect of adjuvant breast irradiation: case report and review of the literature. Strahlenther Onkol. 2018; 194 (11): 1060-1065.

  5. Gonzalez-Ericsson PI, Estrada MV, Al-Rohil R, Sanders ME. Post-irradiation morphoea of the breast: a case report and review of the literature. Histopathology. 2018; 72 (2): 342-350.

  6. Radcliffe CH. Diseases of the skin: their description, pathology, diagnosis, and treatment. London: H.K. Lewis; 1888.

  7. Colver GB, Rodger A, Mortimer PS, Savin JA, Neill SM, Hunter JAA. Post-irradiation morphea. Br J Dermatol. 1989; 120 (6): 831-835.

  8. Newland K, Marshman G. Success treatment of post-irradiation morphoea with acitretin and narrowband UVB. Australas J Dermatol. 2012; 53 (2): 136-138.

  9. Schaffer JV, Carroll C, Dvoretsky I, Huether MJ, Girardi M. Postirradiation morphea of the breast presentation of two cases and review of the literature. Dermatology. 2000; 200 (1): 67-71.

  10. Morganroth PA, Dehoratius D, Curry H, Elenitsas R. Postirradiation morphea: a case report with a review of the literature and summary of the clinicopathologic differential diagnosis. Am J Dermatopathol. 2013. doi: 10.1097/DAD.0b013e3181cb3fdd.

  11. Mosterd K, Winnepenninckx V, Vermeulen A, van Neer PA, van Neer FJ, Frank J. Morphea following surgery and radiotherapy: an evolving problem. J Eur Acad Dermatol Venereol. 2009; 23 (9): 1099-1101.

  12. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: A review of 245 adult and pediatric cases. Arch Dermatol. 2009; 145 (5): 545-550.

  13. Tirado-Rodriguez B, Ortega E, Segura-Medina P, Huerta-Yepez S. TGF-β: an important mediator of allergic disease and a molecule with dual activity in cancer development. J Immunol Res. 2014; 2014: 318481.

  14. Massagué J. TGFbeta in cancer. Cell. 2008; 134 (2): 215-230. doi: 10.1016/j.cell.2008.07.001.

  15. Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015; 141 (11): 1985-1994.

  16. Narbutt J, Holdrowicz A, Lesiak A. Morphea - selected local treatment methods and their effectiveness. Reumatologia. 2017; 55 (6): 305-313.

  17. Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A et al. German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 2016; 14 (2): 199-216.




Figure 1
Figure 2
Figure 3

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

An Med Asoc Med Hosp ABC. 2022;67